Medication Abortion in Jeopardy?

The Gender Justice Brief

Feb 10, 2023•42 min•Season 1Ep. 8

--:--

Listen in podcast apps:

Listen to this episode in Metacast mobile app

Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episode description

Gender Justice Legal Director Jess Braverman and Executive Director Megan Peterson discuss the Alliance Defending Freedom’s lawsuit against the FDA for its approval of Mifepristone over 20 years ago. Mifepristone is the first pill in the two-pill regimen that makes up medication abortion. If successful, the lawsuit could hinder access to medication abortion across the country. The Gender Justice team discusses how this ruling would affect Minnesota providers and patients, as well as new updates on reproductive freedom legislation advancing at the Minnesota legislature this session.

###

Visit the "Gender Justice" Website here and "Unrestrict Minnesota" here.

Erin Hart, Communications Director at Gender Justice, is hosting the Gender Justice Brief.

The GJB is produced by Gunther Michael Jahnl & Audra Grigus.

For the best experience, listen in Metacast app for iOS or Android

Open in Metacast